Discovery and Development of Biofilm Inhibitors that Target c-di-GMP signaling

针对 c-di-GMP 信号传导的生物膜抑制剂的发现和开发

• 批准号: 8268895
• 负责人: Roger G Linington
• 金额: $ 21.44万
• 依托单位: UNIVERSITY OF CALIFORNIA SANTA CRUZ
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8268895
• 关键词: Antibiotic Resistance; Antibiotic Therapy; Antibiotics; Area; Bacteria; Bacterial Infections; Bacteriology; Biochemical; Biological; Biological Factors; Catheters; Cell Survival; Chromatography; Combined Modality Therapy; Complex; Confocal Microscopy; Development; Dose; FDA approved; Fermentation; Fluorescence; Future; Goals; Grant; Growth; High Pressure Liquid Chromatography; Hospitalization; Human; Image; Image Analysis; In Vitro; Infection; Knowledge; Laboratories; Lead; Libraries; Life; Liquid Chromatography; Luciferases; Lung; Marines; Measures; Mediating; Methods; Microbial Biofilms; Microscopy; Molecular Genetics; Molecular Mechanisms of Action; Molecular Target; National Cancer Institute; Peach; Phase; Physiology; Process; Production; Proteins; Pseudomonas aeruginosa; Reporter; Robotics; Screening procedure; Signal Pathway; Signal Transduction; Small Molecule Chemical Library; Source; Staining method; Stains; Stents; Surface; Techniques; Technology; Testing; Therapeutic; Vibrio cholerae; Work; artificial lung; base; bis(3' ,5' )-cyclic diguanylic acid; cystic fibrosis patients; drug development; fluorescence imaging; functional genomics; implantable device; inhibitor/antagonist; large scale production; marine natural product; medical implant; member; microbial; microorganism; mutant; novel; novel therapeutics; overexpression; pathogen; pre-clinical; prevent; promoter; small molecule; stereochemistry; sugar; tool

DESCRIPTION (provided by applicant): It is estimated that over 75% of human bacterial infections are biofilm-related, yet relatively little is known about the biochemical mechanisms that govern biofilm formation. The development of a greater understanding of biofilm physiology therefore has profound implications for both basic bacteriology, and biomedical applications. In particular, the discovery of small molecule inhibitors of biofilm formation provides an opportunity to create a set of target-independent tools for delineating the complex regulatory cascade that control biofilm formation, and to develop new therapeutics for biofilm-related infections. We have recently developed an image-based, high content screening approach for visualizing biofilm inhibitors under high-throughput conditions. Application of this screening technology to the National Cancer Institute screening libraries has shown that this tool can be used to effectively identify biofilm inhibitors form small molecule screening libraries. Within the scope o this grant, we aim to further refine and optimize this screening platform to include the human pathogen Pseudomonas aeruginosa, and to identify those compounds that selectively impact cyclic-di-GMP signaling pathways; a major regulatory mechanism in biofilm formation. Secondly, we aim to explore the modes of action of these probes through a suite of analyses, including confocal microscopy, functional genomics and molecular genetics. We further aim to examine the effect on bacterial viability of co-dosing biofilm inhibitors with conventional antibiotic therapies to explore their utility as combination therapies for treatment of bacterial biofilm infections. Finally, we will develop sustainable methods of production of lead compounds through fermentation optimization studies to prepare lead candidate projects for pre-clinical development. PUBLIC HEALTH RELEVANCE: Bacterial infections remain one of the leading causes of hospitalization in the developed world. In many instances, these infections are made more difficult to treat by the presence of bacterial biofilms. Biofilms are layers of bacterial 'slime', which coat both biological surfaces (such as the lining of the lung) and artificial surfaces (such as stents and catheters). Biofilms create a dense matrix of proteins and sugars, and protect the bacteria from the action of antibiotics. This project aims to find small molecules that disrupt the formation of biofilms, and to use these compounds to better understand the mechanisms by which biofilms are formed, using state-of-the-art fluorescence imaging microscopy and small molecule chemical libraries.

描述（由申请人提供）：据估计，超过75%的人类细菌感染与生物膜有关，但对控制生物膜形成的生化机制知之甚少。因此，对生物膜生理学的进一步了解对基础细菌学和生物医学应用都具有深远的意义。特别是，生物膜形成的小分子抑制剂的发现提供了一个机会